Radotinib HCl, Placebo for Radotinib HCl
RT51EP1902
Phase 2 small_molecule active
Quick answer
Radotinib HCl, Placebo for Radotinib HCl for Treatment of Parkinson’s disease (PD) is a Phase 2 program (small_molecule) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Treatment of Parkinson’s disease (PD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active